Silver Nanoparticles in Therapeutics: Antimicrobial Gel

PDF Publication Title:

Silver Nanoparticles in Therapeutics: Antimicrobial Gel ( silver-nanoparticles-therapeutics-antimicrobial-gel )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 009

SilVer Nanoparticle Based Formulation for Topical Use articles Table 4. Susceptibility of P. aeruginosa to Individual Agents and Results of Checkerboard Microdilution Studies drug ceftazidime (CF) streptomycin (ST) kanamycin (K) ampiclox (AC) polymyxin B (P) chloramphenicol (CHL) SNP MIC (μg/mL) 0.78 3.12 12.5 1.95 1.56 12.5 3.12 drug combination MIC (μg/mL) CF (0.39) + SNP (0.78) ST (3.12) + SNP (0.39) K (12.5) + SNP (0.39) AC (1.95) + SNP (0.39) P (1.56) + SNP (0.195) CHL (25) + SNP (1.56) FICi interaction 0.75 synergistic 1.125 additive 1.125 additive 1.125 additive 1.0625 additive 2.5 antagonistic protein in control cells). SOD levels were found to be ∼1.4- fold higher for SNP treated cells (4.97 μmol/mg) as compared to unexposed cells (3.47 μmol/mg protein). However, changes observed in the levels of lipid peroxidation and GPx were not statistically significant (p > 0.05). The apoptotic thresholds of SNP were monitored by caspase-3 assay after exposure to SNP for a range of doses (0.39-350 μg/mL), and the results of a representative dose- range study are shown in Figure 10. SNP could induce apoptosis at concentrations in the range of 6.25-250 μg/ mL. The study was complemented by microscopic observa- tions on cells. Exposure to 125 μg/mL (∼(1/2)IC50) SNP resulted in apoptosis (as evidenced by bright green nucleus with condensed or fragmented chromatin under CLSM, upon AO/EB double staining) of cells (Figure 11B). Further, at SNP concentration 500 μg/mL (∼2 × IC50) cells with structurally normal but orange stained nuclei were observed Figure 5. Time kill study performed using SNP against C. albicans at MIC and MFC (error bars not shown as deviations from the mean values are <0.1 × log 10). Figure 6. Inhibition of MMP-2 (gelatinase A) enzyme in the presence of SNP (error bars not shown as deviations from the mean values are <1%). (Figure 11C), suggesting necrosis. Table 5 shows quantitative data on the percentage of live, apoptotic and necrotic cells after exposure to ∼(1/2)IC50 and ∼2 × IC50 SNP as compared to control cells which was obtained using fluo- rescence microscopy after AO/EB double staining. Data showed 67% live cells, 28% apoptotic cells and 5% necrotic cells at SNP concentration of 125 μg/mL (∼(1/2)IC50) whereas 53% live cells, 11% apoptotic cells and 36% necrotic cells were noticed at 500 μg/mL SNP concentration (∼2 × IC50). The above experiments demonstrating the antibacterial, antifungal nature of SNP as well as those proving its anti- inflammatory activity, cytotoxicity, intracellular localization and biochemical changes relating to metal stress response were carried out using aqueous a colloidal suspension of SNP. The following paragraphs describe results of the study on gel formulation containing SNP, i.e., S-gel (Figure 12). Table 6 and Figure 12 show the results of in vitro antibacterial activity of S- gel. The zone of inhibition for S-gel was in the range of 3 to 10 mm at 0.020 mg/g of gel. Maximum antibacterial activity (10 mm) of S-gel was noted against Pseudomonas sp. At higher concentration of silver (0.1 mg/g) S-gel showed a significantly wider zone of Figure 7. Percent viability measured by XTT assay on Hep G2 cells after treatment with SNP (12.5 μg/mL to 400 μg/mL) for 24 h. The data are expressed as mean ( standard deviation (SD) of three independent experiments. An OD value of control cells (unexposed cells) was taken as 100% viability (0% cytotoxicity). Asterisk (*) denotes a statistically significant difference compared to control (p < 0.05). VOL. 6, NO. 5 MOLECULAR PHARMACEUTICS 1395

PDF Image | Silver Nanoparticles in Therapeutics: Antimicrobial Gel

PDF Search Title:

Silver Nanoparticles in Therapeutics: Antimicrobial Gel

Original File Name Searched:

SilverNanoparticlesinTherapeutics-TopicalUse.pdf

DIY PDF Search: Google It | Yahoo | Bing

Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info

Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info

All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info

CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info

Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info

Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info

Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.

Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.

CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com (Standard Web Page)